Renaissance Technologies Portfolio holdings
Renaissance Technologies LLC, founded in 1982 by mathematician James Simons as Monemetrics and headquartered in East Setauket, New York, is a legendary quantitative hedge fund managing around $65 billion in assets as of late 2024, renowned for its pioneering use of mathematical models and algorithms in trading. Starting with currency trading and evolving into a secretive powerhouse under its flagship Medallion Fund—launched in 1988—the firm employs PhDs, physicists, and computer scientists to analyze vast datasets, executing high-frequency trades across equities, futures, and derivatives with returns averaging over 66% annually before fees from 1988 to 2018. Simons, who stepped down as chairman in 2021, built a culture of intellectual rigor, limiting Medallion to employees and insiders since 1993 while offering institutional funds like the Renaissance Institutional Equities Fund (RIEF) to outsiders. Now led by Peter Brown and Robert Mercer’s successors, Renaissance remains a benchmark for quant investing, blending academic precision with a low-profile, extraordinarily profitable legacy despite occasional regulatory scrutiny.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
NVIDIA
NVDA
|
+$798M |
| 2 |
Netflix
NFLX
|
+$608M |
| 3 |
UnitedHealth
UNH
|
+$517M |
| 4 |
Apple
AAPL
|
+$461M |
| 5 |
GE Vernova
GEV
|
+$296M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Broadcom
AVGO
|
+$527M |
| 2 |
Alphabet (Google) Class A
GOOGL
|
+$372M |
| 3 |
Meta Platforms (Facebook)
META
|
+$362M |
| 4 |
Advanced Micro Devices
AMD
|
+$328M |
| 5 |
Palantir
PLTR
|
+$327M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 19.57% |
| 2 | Healthcare | 15.79% |
| 3 | Consumer Discretionary | 12.36% |
| 4 | Financials | 11.53% |
| 5 | Industrials | 8.92% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | Held Since | |
|---|---|---|---|---|---|---|---|
951
BJ's Restaurants
BJRI
$1.27B
| $12.2M | 0.02% |
274,429
+215,100
| +363% | +$8.49M |
2025 Q1
1 quarter
|
|
952
Kilroy Realty
KRC
$3.98B
| $12.2M | 0.02% |
355,700
-120,000
| -25% | -$3.91M |
2024 Q1
5 quarters
|
|
953
First American
FAF
$6.25B
| $12.2M | 0.02% |
197,945
+52,245
| +36% | +$3.1M |
2016 Q1
37 quarters
|
|
954
Utah Medical Products
UTMD
$237M
| $12.1M | 0.02% |
213,314
-4,400
| -2% | -$239K |
2013 Q2
48 quarters
|
|
955
Philip Morris
PM
$314B
| $12.1M | 0.02% |
66,400
-150,100
| -69% | -$25.8M |
2024 Q4
2 quarters
|
|
|
PAMT
956
PAMT Corp
PAMT
$268M
| $12.1M | 0.02% |
938,202
-16,100
| -2% | -$216K |
2013 Q2
48 quarters
|
|
957
SolarEdge
SEDG
$1.98B
| $12.1M | 0.02% |
+591,600
| New | +$9.79M |
2025 Q2
0 quarters
|
|
958
Rocket Companies
RKT
$32.5B
| $12.1M | 0.02% |
+850,300
| New | +$11M |
2025 Q2
0 quarters
|
|
|
GPGI
959
GPGI Inc
GPGI
$3.65B
| $12M | 0.02% |
849,200
+293,500
| +53% | +$3.6M |
2022 Q4
10 quarters
|
|
960
Leonardo DRS
DRS
$9.67B
| $12M | 0.02% |
257,200
+111,200
| +76% | +$4.47M |
2024 Q3
3 quarters
|
|
961
Monarch Casino & Resort
MCRI
$2.05B
| $12M | 0.02% |
138,300
-11,900
| -8% | -$960K |
2021 Q3
15 quarters
|
|
962
Idacorp
IDA
$7.83B
| $11.9M | 0.02% |
103,500
-39,900
| -28% | -$4.62M |
2016 Q1
37 quarters
|
|
963
Vornado Realty Trust
VNO
$6.28B
| $11.9M | 0.02% |
311,699
+199,300
| +177% | +$7.46M |
2025 Q1
1 quarter
|
|
964
NETGEAR
NTGR
$641M
| $11.9M | 0.02% |
409,955
-32,400
| -7% | -$870K |
2020 Q2
20 quarters
|
|
965
StealthGas
GASS
$341M
| $11.9M | 0.02% |
1,854,856
+99,780
| +6% | +$572K |
2013 Q2
48 quarters
|
|
966
Boyd Gaming
BYD
$5.01B
| $11.9M | 0.02% |
151,500
+12,600
| +9% | +$900K |
2024 Q3
3 quarters
|
|
967
Capital One
COF
$122B
| $11.9M | 0.02% |
+55,704
| New | +$10.4M |
2025 Q2
0 quarters
|
|
968
Nike
NKE
$51.6B
| $11.8M | 0.02% |
+166,741
| New | +$10M |
2025 Q2
0 quarters
|
|
969
Nutrien
NTR
$32.2B
| $11.8M | 0.02% |
+202,811
| New | +$11.5M |
2025 Q2
0 quarters
|
|
970
Ooma
OOMA
$553M
| $11.8M | 0.02% |
914,803
+76,913
| +9% | +$978K |
2016 Q1
37 quarters
|
|
971
M/I Homes
MHO
$3.23B
| $11.8M | 0.02% |
105,100
-53,500
| -34% | -$5.81M |
2024 Q1
5 quarters
|
|
|
VERV
972
DELISTED
Verve Therapeutics
VERV
| $11.8M | 0.02% |
1,047,600
+866,800
| +479% | +$4.94M |
2023 Q4
6 quarters
|
|
973
Fidelity Total Bond ETF
FBND
$28B
| $11.7M | 0.02% |
256,400
+249,000
| +3,365% | +$11.3M |
2025 Q1
1 quarter
|
|
974
Maximus
MMS
$3.11B
| $11.7M | 0.02% |
167,000
+106,700
| +177% | +$7.5M |
2017 Q4
30 quarters
|
|
975
LifeVantage
LFVN
$75.5M
| $11.7M | 0.02% |
894,418
+30,500
| +4% | +$394K |
2014 Q1
45 quarters
|
|
Similar funds
Renaissance Technologies's Q2 2025 Portfolio in Review
As of Q2 2025, Renaissance Technologies held 4,018 positions worth $75.2B, up 14% from $66.1B the previous quarter. Its ten largest holdings account for 12% of the portfolio.
Renaissance Technologies's Q2 2025 filing shows 612 new, 1,577 increased, 1,314 reduced and 496 closed positions. Its largest new stake was UnitedHealth: 1,352,129 shares worth $422M. The largest sale was Broadcom, an estimated $527M.
By sector, the portfolio is most concentrated in Technology at 20% of assets, up from 17% a quarter earlier, followed by Healthcare and Consumer Discretionary.
- Renaissance Technologies's largest Q2 2025 buy was UnitedHealth: 1,352,129 shares worth $422M.
- Renaissance Technologies added most to NVIDIA in Q2 2025, an estimated $798M increase.
- Renaissance Technologies's biggest Q2 2025 reduction was Broadcom, cutting an estimated $527M.
- Renaissance Technologies fully exited Advanced Micro Devices in Q2 2025, selling an estimated $328M.
- Renaissance Technologies's ten largest holdings make up 12% of its $75.2B portfolio in Q2 2025.
- Renaissance Technologies opened 612 new positions and closed 496 in Q2 2025.
- Renaissance Technologies's portfolio value rose 14% quarter-over-quarter to $75.2B.
Based on Renaissance Technologies's 13F filing for Q2 2025, filed 13 Aug 2025.